PixarBio Corporation (PXRB)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0000 - Volume
100 - Avg. Volume
100 - Market Cap (intraday)
81 - Beta (5Y Monthly) -54.42
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1890 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.
www.pixarbio.com30
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: PXRB
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PXRB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PXRB
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
7.5k
Net Income Avi to Common (ttm)
-12.19M
Diluted EPS (ttm)
-0.1890
Balance Sheet and Cash Flow
Total Cash (mrq)
715.11k
Total Debt/Equity (mrq)
32.66%
Levered Free Cash Flow (ttm)
--
Company Insights: PXRB
PXRB does not have Company Insights